NYSE:BAX - New York Stock Exchange, Inc. - US0718131099 - Common Stock - Currency: USD
36.57
+1.13 (+3.19%)
The current stock price of BAX is 36.57 USD. In the past month the price increased by 18.7%. In the past year, price decreased by -16.45%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 29.37 | 237.84B | ||
ISRG | INTUITIVE SURGICAL INC | 70.7 | 184.84B | ||
BSX | BOSTON SCIENTIFIC CORP | 39.49 | 146.29B | ||
SYK | STRYKER CORP | 31.12 | 144.73B | ||
MDT | MEDTRONIC PLC | 17.7 | 121.20B | ||
BDX | BECTON DICKINSON AND CO | 16.5 | 65.91B | ||
EW | EDWARDS LIFESCIENCES CORP | 26.84 | 41.35B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 19.28 | 39.59B | ||
IDXX | IDEXX LABORATORIES INC | 38.23 | 34.98B | ||
RMD | RESMED INC | 26.29 | 34.14B | ||
DXCM | DEXCOM INC | 47.18 | 30.42B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 18.25 | 25.91B |
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. The company is headquartered in Deerfield, Illinois and currently employs 60,000 full-time employees. The Company’s Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant and adhesion prevention products. Its Healthcare Systems and Technologies segment includes connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including surgical video technologies and precision positioning devices. Its Pharmaceuticals segment includes specialty injectable pharmaceuticals, inhaled anesthesia and drug compounding. Its Kidney Care segment includes chronic and acute dialysis therapies and services, including peritoneal dialysis, hemodialysis, continuous renal replacement therapies (CRRT) and other organ support therapies.
BAXTER INTERNATIONAL INC
1 Baxter Parkway,
Deerfield ILLINOIS 60015 US
CEO: Jose E. Almeida
Employees: 60000
Company Website: https://www.baxter.com/
Investor Relations: https://investor.baxter.com
Phone: 18442945418
The current stock price of BAX is 36.57 USD. The price increased by 3.19% in the last trading session.
The exchange symbol of BAXTER INTERNATIONAL INC is BAX and it is listed on the New York Stock Exchange, Inc. exchange.
BAX stock is listed on the New York Stock Exchange, Inc. exchange.
22 analysts have analysed BAX and the average price target is 39.9 USD. This implies a price increase of 9.11% is expected in the next year compared to the current price of 36.57. Check the BAXTER INTERNATIONAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BAXTER INTERNATIONAL INC (BAX) has a market capitalization of 18.71B USD. This makes BAX a Large Cap stock.
BAXTER INTERNATIONAL INC (BAX) currently has 60000 employees.
BAXTER INTERNATIONAL INC (BAX) has a support level at 36.56. Check the full technical report for a detailed analysis of BAX support and resistance levels.
The Revenue of BAXTER INTERNATIONAL INC (BAX) is expected to grow by 5.86% in the next year. Check the estimates tab for more information on the BAX EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BAXTER INTERNATIONAL INC (BAX) has a dividend yield of 1.92%. The yearly dividend amount is currently 1.16. Check the full fundamental report for a detailed analysis of BAX dividend history, reliability and sustainability.
BAXTER INTERNATIONAL INC (BAX) will report earnings on 2025-04-30, before the market open.
The PE ratio for BAXTER INTERNATIONAL INC (BAX) is 13.49. This is based on the reported non-GAAP earnings per share of 2.71 and the current share price of 36.57 USD. Check the full fundamental report for a full analysis of the valuation metrics for BAX.
The outstanding short interest for BAXTER INTERNATIONAL INC (BAX) is 3.51% of its float. Check the ownership tab for more information on the BAX short interest.
ChartMill assigns a technical rating of 7 / 10 to BAX. When comparing the yearly performance of all stocks, BAX turns out to be only a medium performer in the overall market: it outperformed 49.97% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to BAX. While BAX is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months BAX reported a non-GAAP Earnings per Share(EPS) of 2.71. The EPS increased by 0.37% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -2.52% | ||
ROE | -9.32% | ||
Debt/Equity | 1.79 |
ChartMill assigns a Buy % Consensus number of 68% to BAX. The Buy consensus is the average rating of analysts ratings from 22 analysts.
For the next year, analysts expect an EPS growth of -8.1% and a revenue growth 5.86% for BAX